Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

epithelial ovarian cancer

  • You have access
    Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
    ANGIOLO GADDUCCI, STEFANIA COSIO, FABIO LANDONI, ANDREA ALBERTO LISSONI, PAOLO ZOLA, MARIA ELENA LAUDANI, ANTONIO ARDIZZOIA, ANGELA GAMBINO and ENRICO SARTORI
    Anticancer Research April 2022, 42 (4) 2017-2022; DOI: https://doi.org/10.21873/anticanres.15681
  • You have access
    Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer
    WONKYO SHIN, JOSEPH J. NOH, SEUNG HUN BAEK, BYOUNG-GIE KIM, MYONG CHEOL LIM and SANG-YOON PARK
    Anticancer Research September 2021, 41 (9) 4603-4607; DOI: https://doi.org/10.21873/anticanres.15273
  • Open Access
    Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study
    ANGIOLO GADDUCCI, ENRICO SIMONETTI, FEDERICA GUIDOCCIO, GIANPIERO MANCA, ASSUERO GIORGETTI, TOMMASO DEPALO, STEFANIA COSIO, MARIO MICCOLI and DUCCIO VOLTERRANI
    Anticancer Research April 2021, 41 (4) 1937-1944; DOI: https://doi.org/10.21873/anticanres.14960
  • You have access
    Positron Emission Tomography/Computed Tomography in Platinum-sensitive Recurrent Ovarian Cancer: A Single-center Italian Study
    ANGIOLO GADDUCCI, ENRICO SIMONETTI, GIANPIERO MANCA, FEDERICA GUIDOCCIO, ANTONIO FANUCCHI, STEFANIA COSIO and DUCCIO VOLTERRANI
    Anticancer Research April 2020, 40 (4) 2191-2197; DOI: https://doi.org/10.21873/anticanres.14180
  • You have access
    Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study
    ANGIOLO GADDUCCI, STEFANIA COSIO, ANDREA ALBERTO LISSONI, VALENTINA ZIZIOLI, MARCO ADORNI, ANNA MARIA FERRERO, FABIO LANDONI and ENRICO SARTORI
    Anticancer Research March 2020, 40 (3) 1543-1550; DOI: https://doi.org/10.21873/anticanres.14100
  • You have access
    Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer
    MARIA V. CHRISTENSEN, CLAUS HØGDALL, STEFFEN G. JENSEN, NOOR LOKMAN, CARMELA RICCIARDELLI, IB J. CHRISTENSEN, PERNILLE CHRISTIANSEN, JULIE BRASK, MONA A. KARLSEN, THERESE K. NISSEN, KIRSTEN M. JOCHUMSEN and ESTRID HØGDALL
    Anticancer Research May 2019, 39 (5) 2475-2482; DOI: https://doi.org/10.21873/anticanres.13367
  • You have access
    Diagnostic Power of Selected Cytokines, MMPs and TIMPs in Ovarian Cancer Patients – ROC Analysis
    GRAŻYNA EWA BĘDKOWSKA, BARBARA PISKÓR, EWA GACUTA, MONIKA ZAJKOWSKA, JOANNA OSADA, MACIEJ SZMITKOWSKI, MILENA DĄBROWSKA and SŁAWOMIR ŁAWICKI
    Anticancer Research May 2019, 39 (5) 2575-2582; DOI: https://doi.org/10.21873/anticanres.13380
  • You have access
    Assessment of the Applicability of Integrative Tumor Response Assays in Advanced Epithelial Ovarian Cancer
    JU-HYUN KIM, YONG SIK YOON, JIN CHEON KIM and YONG-MAN KIM
    Anticancer Research January 2019, 39 (1) 313-318; DOI: https://doi.org/10.21873/anticanres.13113
  • You have access
    Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5’ and 3’ Exons
    KYUNG JIN EOH, HYUNG SEOK PARK, JI SOO PARK, SEUNG-TAE LEE, JUNG WOO HAN, JUNG-YUN LEE, SUNGHOON KIM, SANG WUN KIM, YOUNG TAE KIM and EUN JI NAM
    Anticancer Research December 2018, 38 (12) 6947-6953; DOI: https://doi.org/10.21873/anticanres.13073
  • You have access
    Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
    SIMON DUCOULOMBIER, FRANÇOIS GOLFIER, OLIVIER COLOMBAN, DAVID BENAYOUN, PIERRE-ADRIEN BOLZE, MICHEL TOD and BENOIT YOU
    Anticancer Research December 2017, 37 (12) 6879-6886;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire